UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Jessup Wealth Management Inc

Jessup Wealth Management Inc trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 90.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,180 shares of the healthcare conglomerate’s stock after selling 10,711 shares during the period. Jessup Wealth Management Inc’s holdings in UnitedHealth Group were worth $597,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of UNH. AlphaMark Advisors LLC bought a new position in UnitedHealth Group during the fourth quarter valued at about $30,000. RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group in the 3rd quarter worth approximately $37,000. DecisionPoint Financial LLC lifted its stake in UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after purchasing an additional 62 shares during the last quarter. Highline Wealth Partners LLC acquired a new position in UnitedHealth Group in the third quarter worth approximately $55,000. Finally, Legacy Investment Solutions LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter valued at $57,000. Institutional investors own 87.86% of the company’s stock.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.33% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on UNH. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Barclays reduced their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Deutsche Bank Aktiengesellschaft upped their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. Wells Fargo & Company cut their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Finally, Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Trading Up 2.0 %

NYSE:UNH opened at $510.75 on Thursday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company’s 50 day moving average is $520.62 and its 200-day moving average is $561.67. The firm has a market cap of $470.03 billion, a price-to-earnings ratio of 32.95, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period last year, the business posted $5.83 earnings per share. The firm’s revenue was up 6.8% compared to the same quarter last year. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.